Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
CMTA and ToolGen Announce CMT1A Collaboration
…CMTA has been able to establish research partnerships with almost 40 pharmaceutical and biotech companies, and leading research labs around the world.” The testing alliance with ToolGen involves access to…
Diana Bharucha-Goebel, MD Joins the CMTA-STAR Advisory Board
In a suite of exciting appointments, the Charcot-Marie-Tooth Association (CMTA) Strategy to Accelerate Research (STAR) Advisory Board is delighted to announce the appointment of Dr. Diana Bharucha-Goebel to their Clinical…
CMTA Adds Drug Development Expert Martine Garnier to STAR Advisory Board
…disease. It does so with an aggressive, multipronged attack, bringing together a group of top-flight researchers and experts and directly funding their work. CMTA launched its Strategy to Accelerate Research,…
A Comprehensive Guide to Clinical Trials
As the CMTA’s $23.5 million investment in research begins to return dividends, more and more potential treatments are advancing to the clinical trial stage. Here’s a quick guide to clinical…
CMT Awareness Month 2023
…color print. Check out the Sky of Fame. Register for the 2023 Patient & Research Summit The 2023 CMTA Patient & Research Summit on Saturday, November 4th will offer life-improving…
CMTAWinter2021Report
CMTA Announces New Center of Excellence at UC Davis Health
The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) research, is proud to announce the designation of Lisa Williams, MD, at UC Davis Health in Sacramento,…
CMTA’s $240K Investment Targets Gene Replacement Therapy in CMT4 Subtypes
…the Strategy to Accelerate Research (STAR) initiative, CMTA has been at the forefront of accelerating gene replacement therapies for CMT, underscoring our leadership in this critical area of research,” said…
Seattle Focus Group with Acceleron Pharma
We are pleased to announce another opportunity to get involved with the CMTA’s Patients as Partners in Research initiative! The goal of Patients as Partners in Research is to advance…
CMTA-STAR Collaboration Celebrates a Decade of CMT Genetic Discovery Through the GENESIS Database
Exciting progress from CMTA’s Strategy To Accelerate Research (STAR) program is once again highlighted with a recent publication celebrating a decade of CMT genomics discovery made possible by the GENESIS…